TELA Bio, Inc. (TELA) Stock

Healthcare · Medical Devices · Member of Other US Stocks

TELA Bio, Inc. (TELA) closed at USD 1.10 on 2026-10-14, a change of -24 % over the past year, with a market capitalization of USD 45.59M.

TELA Bio, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

TELA Bio, Inc. key figures

Previous close

USD 1.10 (2026-10-14)

1-year change

-24 %

Market cap

USD 45.59M

Enterprise value

USD 72.84M

P/E ratio (trailing)

-1.38

P/E ratio (forward)

-2.24

EPS (trailing)

-0.73

EPS (forward)

-0.45

PEG ratio

n/a

Price to book

-2.85

Revenue growth

-4.5 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

1.72

Employees

218

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About TELA Bio, Inc.

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for TELA Bio, Inc. and compare it with other stocks.